Reviewed By
Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 28 Researches
7.6
USERS' SCORE
Good
Based on 3 Reviews
8
Supplement Facts
Serving Size: 5 Tablets
Amount Per Serving
%DV
Vitamin D3 (as cholecalciferol)
10 mcg (400 IU)
50%
Calcium (as calcium citrate)
1,000 mg
77%
Magnesium (as magnesium oxide, magnesium citrate)
500 mg
119%
Sodium
20 mg
<1%
Top Medical Research Studies
9
We conducted a rigorous study to explore how vitamin D3 supplementation might influence headaches in people suffering from migraines. By utilizing a well-structured, placebo-controlled, double-blind design, we included 80 participants with episodic migraines, assigning them either a daily dose of vitamin D3 or a placebo for 12 weeks.
After the study, we observed significant improvements in those receiving vitamin D3. Participants reported fewer headache days each month, shorter headache durations, and less severe pain overall. They also used fewer pain relievers compared to those on placebo, showcasing the potential benefit of vitamin D3 in managing migraine symptoms.
Our findings suggest that vitamin D3 not only aids in reducing headache frequency but may also play a role in addressing inflammation, as evidenced by reduced levels of certain inflammatory markers in the blood. This highlights its possible therapeutic value for migraine sufferers, indicating that a daily dose could make a meaningful difference in their lives.
After the study, we observed significant improvements in those receiving vitamin D3. Participants reported fewer headache days each month, shorter headache durations, and less severe pain overall. They also used fewer pain relievers compared to those on placebo, showcasing the potential benefit of vitamin D3 in managing migraine symptoms.
Our findings suggest that vitamin D3 not only aids in reducing headache frequency but may also play a role in addressing inflammation, as evidenced by reduced levels of certain inflammatory markers in the blood. This highlights its possible therapeutic value for migraine sufferers, indicating that a daily dose could make a meaningful difference in their lives.
Read More
8
We conducted a rigorous study to determine whether vitamin D3 supplementation could help improve the lives of adults suffering from migraines. Our approach involved a well-structured, randomized, double-blinded, placebo-controlled trial, which included 36 women and 12 men, aged between 18 to 65 years.
Participants underwent a 4-week baseline period before being randomly assigned to receive either 100 μg/day of D3 vitamin or a placebo for 24 weeks. Throughout the study, we kept track of migraine attacks and various symptoms through self-reported diaries, logging important details like the frequency and severity of their migraines.
Our findings were quite promising. Those taking D3 vitamin experienced fewer migraine days compared to those on the placebo, suggesting that vitamin D3 could serve as an effective preventative treatment for migraine management. However, we noted that further studies with larger sample sizes would be beneficial to solidify these claims and fully understand the potential role of vitamin D3 in migraine prevention.
Participants underwent a 4-week baseline period before being randomly assigned to receive either 100 μg/day of D3 vitamin or a placebo for 24 weeks. Throughout the study, we kept track of migraine attacks and various symptoms through self-reported diaries, logging important details like the frequency and severity of their migraines.
Our findings were quite promising. Those taking D3 vitamin experienced fewer migraine days compared to those on the placebo, suggesting that vitamin D3 could serve as an effective preventative treatment for migraine management. However, we noted that further studies with larger sample sizes would be beneficial to solidify these claims and fully understand the potential role of vitamin D3 in migraine prevention.
Read More
9
Magnesium aids migraine management
We explored the impact of magnesium on migraine headaches, focusing on its potential benefits based on various studies. Magnesium deficiency is quite common and can arise from different factors, such as not consuming enough through diet or losing more through bodily systems.
A wealth of research, including case reports and controlled trials, suggests that magnesium supplementation can effectively alleviate migraines, both in the short term and long term. The proposed reasons for this effectiveness range from magnesium's role in preventing spreading cortical depression to its ability to manage oxidative stress and inflammation.
This evidence leads us to consider magnesium not just as a dietary supplement but as an important player in migraine management. Understanding these links helps us contemplate magnesium’s role in prevention and treatment, promising a potential path for those who suffer from this debilitating condition.
A wealth of research, including case reports and controlled trials, suggests that magnesium supplementation can effectively alleviate migraines, both in the short term and long term. The proposed reasons for this effectiveness range from magnesium's role in preventing spreading cortical depression to its ability to manage oxidative stress and inflammation.
This evidence leads us to consider magnesium not just as a dietary supplement but as an important player in migraine management. Understanding these links helps us contemplate magnesium’s role in prevention and treatment, promising a potential path for those who suffer from this debilitating condition.
Read More
Most Useful Reviews
9
Migraine relief
2 people found this helpful
Helps with migraines. A nutritionist recommended this brand primarily for migraines, and I've found it beneficial. I take three a day and notice they help in keeping headaches at bay without causing nausea like many other vitamins.
Read More
9
Effective for headaches
I liked it! The doctor prescribed magnesium injections for my headaches, but I couldn't find anyone to administer them. Instead, I ordered these pills, and after a week of taking them, my headaches ceased. I also had tests done, and my magnesium levels are now within a good range. I'm very pleased with this product!
Read More
0
Ineffective for headaches
This vitamin didn't work for me. After three doses, a headache developed. I paused, thinking it might be something else, but upon trying again, the headache returned. Every individual's response can vary; this is just my personal experience. The packaging is nice, and the jar is convenient.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 28 Researches
7.6
- All Researches
9.5
We conducted a study to explore the effectiveness of simvastatin combined with vitamin D3 in preventing headaches for adults suffering from episodic migraines. The study involved 57 participants who were randomly assigned either the active treatment or a placebo for 24 weeks, following a 12-week baseline period.
Our findings revealed that those taking simvastatin and vitamin D3 experienced a meaningful reduction in the number of migraine days compared to those on the placebo. In fact, participants on the active treatment saw their migraine days decrease by an average of 8 days during the first 12 weeks, and 9 days during the subsequent weeks, with a statistically significant difference that supports the treatment's effectiveness.
It's also worth mentioning that 25% of the participants on simvastatin and vitamin D3 achieved at least a 50% reduction in migraine days at 12 weeks, which increased to 29% by 24 weeks. This is in stark contrast to just 3% of participants in the placebo group. Importantly, the occurrence of side effects was similar between the groups, suggesting that the treatment was well-tolerated.
Overall, we observed a promising potential for simvastatin and vitamin D3 as a preventative option for those grappling with chronic migraines, while also considering the broader health implications regarding vascular health.
Our findings revealed that those taking simvastatin and vitamin D3 experienced a meaningful reduction in the number of migraine days compared to those on the placebo. In fact, participants on the active treatment saw their migraine days decrease by an average of 8 days during the first 12 weeks, and 9 days during the subsequent weeks, with a statistically significant difference that supports the treatment's effectiveness.
It's also worth mentioning that 25% of the participants on simvastatin and vitamin D3 achieved at least a 50% reduction in migraine days at 12 weeks, which increased to 29% by 24 weeks. This is in stark contrast to just 3% of participants in the placebo group. Importantly, the occurrence of side effects was similar between the groups, suggesting that the treatment was well-tolerated.
Overall, we observed a promising potential for simvastatin and vitamin D3 as a preventative option for those grappling with chronic migraines, while also considering the broader health implications regarding vascular health.
Read More
9.5
We explored the connection between calcium treatment and headaches, particularly in patients with reversible cerebral vasoconstriction syndrome (RCVS). In this case, we observed a healthy young woman who had been using escitalopram for a long time. She presented with bilateral neurological deficits, and after treatment with intra-arterial calcium channel blockers, her symptoms improved significantly.
However, it’s important to note that while calcium channel blockers were administered, the study does not specifically isolate calcium’s effects on headache relief. This combination of treatments makes it challenging to understand how much calcium alone contributes to alleviating headache symptoms, if at all.
As we considered the overall findings, it became clear that while calcium channel blockers can lead to symptom improvement in RCVS, the direct impact of calcium on headaches remains uncertain. Therefore, individuals experiencing thunderclap headaches, especially those on selective serotonin reuptake inhibitors, should consider RCVS as a possible diagnosis, but we cannot definitively conclude that calcium treatment is effective for headaches based on this case alone.
However, it’s important to note that while calcium channel blockers were administered, the study does not specifically isolate calcium’s effects on headache relief. This combination of treatments makes it challenging to understand how much calcium alone contributes to alleviating headache symptoms, if at all.
As we considered the overall findings, it became clear that while calcium channel blockers can lead to symptom improvement in RCVS, the direct impact of calcium on headaches remains uncertain. Therefore, individuals experiencing thunderclap headaches, especially those on selective serotonin reuptake inhibitors, should consider RCVS as a possible diagnosis, but we cannot definitively conclude that calcium treatment is effective for headaches based on this case alone.
Read More
9
We aimed to explore the effects of vitamin D3 supplementation on headaches in children undergoing treatment with topiramate for migraines. In a carefully designed double-blind clinical trial, we involved children aged 5 to 14 years who were experiencing migraines. Participants were randomly divided into two groups: one received topiramate with vitamin D3 supplements, while the other received topiramate along with a placebo.
Over four months, we noted significant enhancements in the group taking vitamin D3. Specifically, this group showed a greater reduction in the frequency of headache attacks and overall migraine disability compared to the placebo group. We observed that 76% of children in the vitamin D3 group reported good responses to the treatment, compared to only 54% in the placebo group.
Importantly, while both groups experienced side effects, those in the vitamin D3 group reported fewer issues. Thus, we found vitamin D3 supplementation to be a well-tolerated and effective addition to topiramate therapy for managing pediatric migraines.
Over four months, we noted significant enhancements in the group taking vitamin D3. Specifically, this group showed a greater reduction in the frequency of headache attacks and overall migraine disability compared to the placebo group. We observed that 76% of children in the vitamin D3 group reported good responses to the treatment, compared to only 54% in the placebo group.
Importantly, while both groups experienced side effects, those in the vitamin D3 group reported fewer issues. Thus, we found vitamin D3 supplementation to be a well-tolerated and effective addition to topiramate therapy for managing pediatric migraines.
Read More
9
In exploring the treatment for headaches associated with post-COVID-19 giant cell arteritis and polymyalgia rheumatica, we observed that vitamin D3 was included alongside more traditional therapies. This was part of a comprehensive treatment approach that also involved pulse methylprednisolone and perineural injection therapy.
While the main focus of treatment appeared to be on corticosteroids and pain management strategies, the exact effect of vitamin D3 on headache relief remains unclear. Since the headaches notably persisted through early treatment stages and improved significantly after additional intervention, we can't conclusively state the efficacy of vitamin D3 in alleviating headache symptoms from this case alone.
It's worth noting that individual responses to treatments can vary widely, and further dedicated studies would be necessary to understand vitamin D3's specific role in headache management. For now, combining it with other treatments was part of a broader strategy to achieve recovery.
While the main focus of treatment appeared to be on corticosteroids and pain management strategies, the exact effect of vitamin D3 on headache relief remains unclear. Since the headaches notably persisted through early treatment stages and improved significantly after additional intervention, we can't conclusively state the efficacy of vitamin D3 in alleviating headache symptoms from this case alone.
It's worth noting that individual responses to treatments can vary widely, and further dedicated studies would be necessary to understand vitamin D3's specific role in headache management. For now, combining it with other treatments was part of a broader strategy to achieve recovery.
Read More
9
Atorvastatin aids migraine control
We explored the relationship between vitamin D3 levels and migraine management in a study involving 68 patients suffering from migraine with aura. Before treatment, participants underwent vitamin D3 level evaluations, and those found to be deficient received vitamin D supplementation. However, while we investigated the effectiveness of adding atorvastatin to sodium valproate for better control of migraine symptoms, the specific effects of vitamin D3 alone on headache were not isolated in this study.
The results indicated that incorporating atorvastatin significantly reduced the severity of pain and the number of attacks. Participants in the atorvastatin group also reported higher satisfaction with their treatment compared to those receiving a placebo. Nonetheless, since the detailed effects of vitamin D3 on headaches were not independently assessed, we can’t conclude anything definitive about its role in headache management from this study alone.
Overall, while statins like atorvastatin show promise in treating migraine, our study did not directly evaluate the benefits of vitamin D3 on headache relief. Further research is needed to clarify vitamin D3's impact in this area.
The results indicated that incorporating atorvastatin significantly reduced the severity of pain and the number of attacks. Participants in the atorvastatin group also reported higher satisfaction with their treatment compared to those receiving a placebo. Nonetheless, since the detailed effects of vitamin D3 on headaches were not independently assessed, we can’t conclude anything definitive about its role in headache management from this study alone.
Overall, while statins like atorvastatin show promise in treating migraine, our study did not directly evaluate the benefits of vitamin D3 on headache relief. Further research is needed to clarify vitamin D3's impact in this area.
Read More
User Reviews
USERS' SCORE
Good
Based on 3 Reviews
8
- All Reviews
- Positive Reviews
- Negative Reviews
9
Migraine relief
2 people found this helpful
Helps with migraines. A nutritionist recommended this brand primarily for migraines, and I've found it beneficial. I take three a day and notice they help in keeping headaches at bay without causing nausea like many other vitamins.
Read More
9
Effective for headaches
I liked it! The doctor prescribed magnesium injections for my headaches, but I couldn't find anyone to administer them. Instead, I ordered these pills, and after a week of taking them, my headaches ceased. I also had tests done, and my magnesium levels are now within a good range. I'm very pleased with this product!
Read More
0
Ineffective for headaches
This vitamin didn't work for me. After three doses, a headache developed. I paused, thinking it might be something else, but upon trying again, the headache returned. Every individual's response can vary; this is just my personal experience. The packaging is nice, and the jar is convenient.
Read More
Frequently Asked Questions
9
Effective for headaches
I liked it! The doctor prescribed magnesium injections for my headaches, but I couldn't find anyone to administer them. Instead, I ordered these pills, and after a week of taking them, my headaches ceased. I also had tests done, and my magnesium levels are now within a good range. I'm very pleased with this product!
0
Ineffective for headaches
This vitamin didn't work for me. After three doses, a headache developed. I paused, thinking it might be something else, but upon trying again, the headache returned. Every individual's response can vary; this is just my personal experience. The packaging is nice, and the jar is convenient.
9
We conducted a study to compare the effectiveness of topiramate, a medication traditionally used for migraine prevention, along with vitamin D3 in children. In a controlled, randomized clinical trial, we looked at children aged 5 to 15 who were experiencing migraines. Half of the participants received topiramate alone, while the other half received topiramate combined with vitamin D3 over two months.
Our findings revealed that both treatments significantly reduced the frequency and severity of migraines. However, the children who took topiramate along with vitamin D3 enjoyed even greater benefits. Specifically, those receiving the combination treatment reported fewer headache days and a lower level of disability due to migraines compared to those on topiramate alone. This combination treatment also led to a higher percentage of participants feeling a good response to their migraine management.
While some mild side effects were noted, they were temporary and similar across both treatment groups, suggesting that this combination is generally safe. Overall, we see that supplementing topiramate with vitamin D3 appears to be a promising strategy for protecting children against migraines.
Our findings revealed that both treatments significantly reduced the frequency and severity of migraines. However, the children who took topiramate along with vitamin D3 enjoyed even greater benefits. Specifically, those receiving the combination treatment reported fewer headache days and a lower level of disability due to migraines compared to those on topiramate alone. This combination treatment also led to a higher percentage of participants feeling a good response to their migraine management.
While some mild side effects were noted, they were temporary and similar across both treatment groups, suggesting that this combination is generally safe. Overall, we see that supplementing topiramate with vitamin D3 appears to be a promising strategy for protecting children against migraines.
5
We delved into the intriguing connection between vitamin D and primary headaches, specifically migraines and tension-type headaches. Our review analyzed various studies up until October 2019, drawing on data from reputable clinical databases. We looked at a total of 22 studies focused on serum vitamin D levels related to headaches, with eight also exploring the effects of vitamin D supplementation.
Interestingly, 18 of these studies found a notable relationship between serum vitamin D levels and headache occurrence, highlighting a particularly strong link with migraines. While this suggests that vitamin D levels may influence headache frequency, we also noted that the evidence is not robust enough to universally recommend vitamin D supplementation for all individuals experiencing headaches.
However, for those suffering from migraines and particularly for individuals with vitamin D deficiency, supplementing with vitamin D might help lessen the intensity or frequency of headaches. Overall, it appears that there could be benefits for specific groups, but more research is needed to clarify the overall impact of vitamin D3 treatment on headaches.
Interestingly, 18 of these studies found a notable relationship between serum vitamin D levels and headache occurrence, highlighting a particularly strong link with migraines. While this suggests that vitamin D levels may influence headache frequency, we also noted that the evidence is not robust enough to universally recommend vitamin D supplementation for all individuals experiencing headaches.
However, for those suffering from migraines and particularly for individuals with vitamin D deficiency, supplementing with vitamin D might help lessen the intensity or frequency of headaches. Overall, it appears that there could be benefits for specific groups, but more research is needed to clarify the overall impact of vitamin D3 treatment on headaches.
9
In exploring the treatment for headaches associated with post-COVID-19 giant cell arteritis and polymyalgia rheumatica, we observed that vitamin D3 was included alongside more traditional therapies. This was part of a comprehensive treatment approach that also involved pulse methylprednisolone and perineural injection therapy.
While the main focus of treatment appeared to be on corticosteroids and pain management strategies, the exact effect of vitamin D3 on headache relief remains unclear. Since the headaches notably persisted through early treatment stages and improved significantly after additional intervention, we can't conclusively state the efficacy of vitamin D3 in alleviating headache symptoms from this case alone.
It's worth noting that individual responses to treatments can vary widely, and further dedicated studies would be necessary to understand vitamin D3's specific role in headache management. For now, combining it with other treatments was part of a broader strategy to achieve recovery.
While the main focus of treatment appeared to be on corticosteroids and pain management strategies, the exact effect of vitamin D3 on headache relief remains unclear. Since the headaches notably persisted through early treatment stages and improved significantly after additional intervention, we can't conclusively state the efficacy of vitamin D3 in alleviating headache symptoms from this case alone.
It's worth noting that individual responses to treatments can vary widely, and further dedicated studies would be necessary to understand vitamin D3's specific role in headache management. For now, combining it with other treatments was part of a broader strategy to achieve recovery.
7
Vitamin D3 impacts immune markers
We explored the effects of vitamin D3 supplementation on migraine patients by conducting a well-structured clinical trial. In this study, eighty episodic migraine sufferers were split into two groups; one group received 2000 IU of vitamin D3 daily, while the other group was given a placebo for 12 weeks. This double-blind, placebo-controlled design aimed to provide a clear understanding of vitamin D3's influence on immune markers associated with migraines.
Our investigation focused on two important immune markers: transforming growth factor-beta (TGF-β) and interleukin-17 (IL-17). After the trial, we observed that the group taking vitamin D3 had a significant increase in TGF-β levels compared to the placebo group, suggesting an improved immune response. In contrast, vitamin D3 appeared to prevent an increase in IL-17 levels, which could indicate a positive effect on the regulation of inflammation.
While these findings are promising and suggest a potential role of vitamin D3 in enhancing the immune balance in migraineurs, it’s important to note that further research is necessary. The study mainly concentrated on immune markers rather than directly addressing headache frequency or intensity, leaving us wanting more detailed insights into vitamin D3’s immediate effects on migraine symptoms.
Our investigation focused on two important immune markers: transforming growth factor-beta (TGF-β) and interleukin-17 (IL-17). After the trial, we observed that the group taking vitamin D3 had a significant increase in TGF-β levels compared to the placebo group, suggesting an improved immune response. In contrast, vitamin D3 appeared to prevent an increase in IL-17 levels, which could indicate a positive effect on the regulation of inflammation.
While these findings are promising and suggest a potential role of vitamin D3 in enhancing the immune balance in migraineurs, it’s important to note that further research is necessary. The study mainly concentrated on immune markers rather than directly addressing headache frequency or intensity, leaving us wanting more detailed insights into vitamin D3’s immediate effects on migraine symptoms.
References
- Kotb Elmala M, Suliman HA, Al-Shokary AH, Ibrahim AO, Kamal NM, et al. The Impact of Vitamin D Supplementation to Topiramate Therapy on Pediatric Migraine Prophylaxis. J Child Neurol. 2022;37:833. 10.1177/08830738221092882
- Mursi AM, Mirghani HO, Elbeialy AA. A Case Report of Post COVID19 Giant Cell Arteritis and Polymyalgia Rheumatica With Visual Loss. Clin Med Insights Case Rep. 2022;15:11795476221088472. 10.1177/11795476221088472
- Ganji R, Majdinasab N, Hesam S, Rostami N, Sayyah M, et al. Does atorvastatin have augmentative effects with sodium valproate in prevention of migraine with aura attacks? A triple-blind controlled clinical trial. J Pharm Health Care Sci. 2021;7:12. 10.1186/s40780-021-00198-8
- Ghorbani Z, Rafiee P, Haghighi S, Razeghi Jahromi S, Djalali M, et al. The effects of vitamin D3 supplementation on TGF-β and IL-17 serum levels in migraineurs: post hoc analysis of a randomized clinical trial. J Pharm Health Care Sci. 2021;7:9. 10.1186/s40780-021-00192-0
- Fallah R, Sarraf Yazd S, Sohrevardi SM. Efficacy of Topiramate Alone and Topiramate Plus Vitamin D3 in the Prophylaxis of Pediatric Migraine: A Randomized Clinical Trial. Iran J Child Neurol. 2020;14:77.
- Ghorbani Z, Rafiee P, Fotouhi A, Haghighi S, Rasekh Magham R, et al. The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial. J Headache Pain. 2020;21:22. 10.1186/s10194-020-01090-w
- Nowaczewska M, Wiciński M, Osiński S, Kaźmierczak H. The Role of Vitamin D in Primary Headache-from Potential Mechanism to Treatment. Nutrients. 2020;12. 10.3390/nu12010243
- Ghorbani Z, Togha M, Rafiee P, Ahmadi ZS, Rasekh Magham R, et al. Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial. Neurol Sci. 2020;41:1183. 10.1007/s10072-019-04220-8
- Ghorbani Z, Togha M, Rafiee P, Ahmadi ZS, Rasekh Magham R, et al. Vitamin D in migraine headache: a comprehensive review on literature. Neurol Sci. 2019;40:2459. 10.1007/s10072-019-04021-z
- Gazerani P, Fuglsang R, Pedersen JG, Sørensen J, Kjeldsen JL, et al. A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D supplementation in adult patients with migraine. Curr Med Res Opin. 2019;35:715. 10.1080/03007995.2018.1519503
- Donmez A, Orun E, Sonmez FM. Vitamin D status in children with headache: A case-control study. Clin Nutr ESPEN. 2018;23:222. 10.1016/j.clnesp.2017.09.010
- Prakash S, Rathore C, Makwana P, Dave A, Joshi H, et al. Vitamin D Deficiency in Patients With Chronic Tension-Type Headache: A Case-Control Study. Headache. 2017;57:1096. 10.1111/head.13096
- Buettner C, Nir RR, Bertisch SM, Bernstein C, Schain A, et al. Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial. Ann Neurol. 2015;78:970. 10.1002/ana.24534
- Laursen JC, Cairns BE, Kumar U, Somvanshi RK, Dong XD, et al. Nitric oxide release from trigeminal satellite glial cells is attenuated by glial modulators and glutamate. Int J Physiol Pathophysiol Pharmacol. 2013;5:228.
- Mottaghi T, Khorvash F, Askari G, Maracy MR, Ghiasvand R, et al. The relationship between serum levels of vitamin D and migraine. J Res Med Sci. 2013;18:S66.
- Postolowski M, Shakil O, Ramachandran L, Rao CV. Reversible Cerebral Vasoconstriction Syndrome Secondary to Escitalopram. Clin Med Res. 2024;22:222. 10.3121/cmr.2025.1864
- Dominguez LJ, Veronese N, Sabico S, Al-Daghri NM, Barbagallo M. Magnesium and Migraine. Nutrients. 2025;17. 10.3390/nu17040725
- Tepper SJ, Tepper K. Nutraceuticals and Headache 2024: Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur. Curr Pain Headache Rep. 2025;29:33. 10.1007/s11916-025-01358-3
- Hannigan IP, Rosengren SM, Di Tanna GL, Watson SRD, Welgampola MS. Effects of nonprescription therapies on vestibular migraine: a questionnaire-based observational study. Intern Med J. 2024;54:916. 10.1111/imj.16314
- Mirzaeva LM, Lobzina AS, Akhmedova KN, Shvartsman GI, Kula II, et al. [Therapeutic approaches to comorbid pathology in episodic migraine and tension-type headache]. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123:52. 10.17116/jnevro202312309152
- Gaul C, Zaranek L, Goßrau G. [Complementary and supplementary procedures in the treatment of headache]. Schmerz. 2023;37:448. 10.1007/s00482-023-00738-1
- Frank M, Abouzari M, Djalilian HR. Meniere's disease is a manifestation of migraine. Curr Opin Otolaryngol Head Neck Surg. 2023;31:313. 10.1097/MOO.0000000000000908
- Verhaak A, Bakaysa S, Johnson A, Veronesi M, Williamson A, et al. Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers. Headache. 2023;63:211. 10.1111/head.14436
- Mahajan R, Anand KS, Mahajan RK, Garg J, Juneja A. Serum Magnesium Levels During the Ictal and Interictal Phase in Patients of Migraine: A Prospective Observational Study. Neurol India. 2022;70:1852. 10.4103/0028-3886.359247
- Wilson A, Hodgetts-Morton VA, Marson EJ, Markland AD, Larkai E, et al. Tocolytics for delaying preterm birth: a network meta-analysis (0924). Cochrane Database Syst Rev. 2022;8:CD014978. 10.1002/14651858.CD014978.pub2
- Bhurat R, Premkumar S, Manokaran RK. Serum Magnesium Levels in Children With and Without Migraine: A Cross-Sectional Study. Indian Pediatr. 2022;59:623.
- Bharadwaj VN, Meyerowitz J, Zou B, Klukinov M, Yan N, et al. Impact of Magnesium on Oxytocin Receptor Function. Pharmaceutics. 2022;14. 10.3390/pharmaceutics14051105
- Martin BR. Multimodal Care for Headaches, Lumbopelvic Pain, and Dysmenorrhea in a Woman With Endometriosis: A Case Report. J Chiropr Med. 2021;20:148. 10.1016/j.jcm.2021.10.002
